Pharma Resources and Bionical Emas Announce Exclusive Global Clinical Trial Supply Partnership

 

Strategic agreement secures access to essential oncology injectables for clinical trials as European shortages intensify

 

HAMELN, GERMANY – 17 JUNE 2025: Pharma Resources GmbH announces an exclusive global clinical trial supply agreement with Bionical Emas, a global provider of Clinical Trial Services. This strategic partnership marks Pharma Resources’ entry into the clinical trial supply market and grants Bionical Emas exclusive rights to distribute its EU-marketed oncology injectables, including Fluorouracil, which is currently in critical shortage across Europe.

The agreement comes at a crucial time, with 5-Fluorouracil shortages disrupting cancer treatments and clinical trials across Europe. Pharma Resources agile supply chain will cut delivery times from months to weeks, ensuring faster, more reliable access to essential medications. By combining advanced demand forecasting with proactive inventory strategies, Bionical Emas and Pharma Resources are addressing long-standing supply chain challenges –accelerating trial timelines and improving flexibility for investigational sites.

 

Juliana Dodillet, Managing Director at Pharma Resources, commented: “We are thrilled to partner with Bionical Emas, whose proven global reach and deep expertise in clinical trial supply make them the ideal partner to support the launch of our first clinical trial supply program and maximize the reach of our oncology injectable portfolio. This collaboration ensures our products can support the development of new therapies and improve patient outcomes, particularly at a time when Fluorouracil shortages are significantly impacting access across Europe.”

 

Tom White, Senior Vice-President, Strategic Alliances at Bionical Emas, commented: "This strategic agreement underscores our unwavering commitment to delivering innovative, patient-focused solutions to the clinical trial community. With our global infrastructure and established expertise in the industry, Pharma Resources has proven to be an exceptionally dedicated and agile partner, and together we're ensuring uninterrupted access to vital oncology treatments for patients worldwide."

 

All clinical trial enquiries should be sent to: pharmaresources@bionicalemas.com